Research Analysts Set Expectations for TriMas Q4 Earnings

TriMas Co. (NASDAQ:TRS) – Stock analysts at Zacks Research lifted their Q4 2024 earnings per share estimates for shares of TriMas in a research report issued to clients and investors on Monday, January 27th. Zacks Research analyst M. Das now forecasts that the industrial products company will post earnings per share of $0.48 for the quarter, up from their previous estimate of $0.47. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q3 2025 earnings at $0.59 EPS, Q4 2026 earnings at $0.50 EPS and FY2026 earnings at $2.10 EPS.

Several other brokerages have also commented on TRS. BWS Financial reiterated a “buy” rating and issued a $40.00 price target on shares of TriMas in a research note on Thursday, January 23rd. StockNews.com raised shares of TriMas from a “sell” rating to a “hold” rating in a research report on Wednesday, November 13th.

TriMas Trading Down 0.7 %

TRS opened at $24.49 on Wednesday. The business’s 50-day simple moving average is $25.03 and its 200-day simple moving average is $25.44. The company has a market cap of $993.61 million, a P/E ratio of 38.27 and a beta of 0.67. TriMas has a one year low of $22.24 and a one year high of $28.51. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83.

TriMas (NASDAQ:TRS) last issued its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). TriMas had a return on equity of 9.21% and a net margin of 2.93%. The firm had revenue of $229.36 million during the quarter, compared to analysts’ expectations of $239.33 million. During the same quarter in the prior year, the firm earned $0.57 EPS. The firm’s revenue was down 2.5% compared to the same quarter last year.

Institutional Investors Weigh In On TriMas

Several large investors have recently modified their holdings of the company. Aristides Capital LLC purchased a new stake in TriMas in the 2nd quarter valued at $245,000. Intech Investment Management LLC purchased a new stake in shares of TriMas in the third quarter valued at about $269,000. Paloma Partners Management Co purchased a new position in shares of TriMas during the third quarter worth about $293,000. XTX Topco Ltd purchased a new position in shares of TriMas during the third quarter worth about $371,000. Finally, Algert Global LLC increased its position in TriMas by 4.2% in the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock valued at $403,000 after acquiring an additional 639 shares during the period. 99.42% of the stock is owned by institutional investors and hedge funds.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.